These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. [Current state and prerequisites for improvement of hormone therapy in cryptorchism (review of the literature)]. Iunda IF, Imshinetskaia LI. Probl Endokrinol (Mosk); 1969 Mar; 15(2):112-6. PubMed ID: 4390008 [No Abstract] [Full Text] [Related]
43. Associations between skin diseases and quality of life: a comparison of psoriasis, vitiligo, and alopecia areata. Ghajarzadeh M, Ghiasi M, Kheirkhah S. Acta Med Iran; 2012 Mar; 50(7):511-5. PubMed ID: 22930385 [Abstract] [Full Text] [Related]
49. [ON INDUCTION OF OVULATION]. VAN DER KERCKHOVE DO. Belg Tijdschr Geneesk; 1964 Aug 01; 20():836-40. PubMed ID: 14179442 [No Abstract] [Full Text] [Related]
50. [ON INDUCTION OF OVULATION]. VANDERKERCKHOVE D. Belg Tijdschr Geneesk; 1964 Aug 01; 20():836-40. PubMed ID: 14178393 [No Abstract] [Full Text] [Related]
51. Vitiligo and alopecia areata associated with subclinical/clinical hypothyroidism. Sehgal VN. Skinmed; 2011 Aug 01; 9(3):192-4. PubMed ID: 21675503 [Abstract] [Full Text] [Related]
52. Treatment of Refractory Segmental Vitiligo and Alopecia Areata in a Child with Upadacitinib and NB-UVB: A Case Report. Mu Y, Pan T, Chen L. Clin Cosmet Investig Dermatol; 2024 Aug 01; 17():1789-1792. PubMed ID: 39132025 [Abstract] [Full Text] [Related]